HALOZYME THERAPEUTICS, INC. ($HALO)
Filing Information
| Accession Number | 0001159036-26-000140 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 8, 2026 |
| Document | View SEC Filing |
Transactions
18
Total Shares
180,000
Total Value
$8,819,700.79
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Oct 6, 2026 | Exercise/Conversion | 20,000 | $18.41 | $368,200.00 | 787,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 6, 2026 | Sale | 2,300 | $107.90 | $248,174.60 | 785,480 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 6, 2026 | Sale | 6,000 | $109.33 | $656,004.00 | 779,480 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 6, 2026 | Sale | 9,920 | $109.89 | $1,090,118.72 | 769,560 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 6, 2026 | Sale | 1,780 | $110.81 | $197,245.36 | 767,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 7, 2026 | Exercise/Conversion | 20,000 | $18.41 | $368,200.00 | 787,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 7, 2026 | Sale | 8,600 | $111.03 | $954,866.60 | 779,180 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 7, 2026 | Sale | 10,300 | $111.84 | $1,151,941.70 | 768,880 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 7, 2026 | Sale | 900 | $112.78 | $101,502.00 | 767,980 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 7, 2026 | Sale | 200 | $113.69 | $22,738.60 | 767,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 8, 2026 | Exercise/Conversion | 20,000 | $18.41 | $368,200.00 | 787,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 8, 2026 | Sale | 4,810 | $108.18 | $520,340.99 | 782,970 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 8, 2026 | Sale | 3,090 | $108.91 | $336,525.72 | 779,880 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 8, 2026 | Sale | 11,900 | $110.00 | $1,308,940.50 | 767,980 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 8, 2026 | Sale | 200 | $110.51 | $22,102.00 | 767,780 | Direct | โ | View Details | |
Director | Option to Purchase Common Stock | Derivative | Oct 6, 2026 | Exercise/Conversion | 20,000 | $18.41 | $368,200.00 | 61,552 | Direct | โ | View Details | |
Director | Option to Purchase Common Stock | Derivative | Oct 7, 2026 | Exercise/Conversion | 20,000 | $18.41 | $368,200.00 | 41,552 | Direct | โ | View Details | |
Director | Option to Purchase Common Stock | Derivative | Oct 8, 2026 | Exercise/Conversion | 20,000 | $18.41 | $368,200.00 | 21,552 | Direct | โ | View Details |